The DOI matches its Crossref record; 183 of the 185 references it cites were found in a registry or an index.
Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2.
Open accessAbstract
The insulin receptor substrate proteins IRS1 and IRS2 are key targets of the insulin receptor tyrosine kinase and are required for hormonal control of metabolism. Tissues from insulin-resistant and diabetic humans exhibit defects in IRS-dependent signalling, implicating their dysregulation in the initiation and progression of metabolic disease. However, IRS1 and IRS2 are regulated through a complex mechanism involving phosphorylation of >50 serine/threonine residues (S/T) within their long, unstructured tail regions. In cultured cells, insulin-stimulated kinases (including atypical PKC, AKT, SIK2, mTOR, S6K1, ERK1/2 and ROCK1) mediate feedback (autologous) S/T phosphorylation of IRS, with both positive and negative effects on insulin sensitivity. Additionally, insulin-independent (heterologous) kinases can phosphorylate IRS1/2 under basal conditions (AMPK, GSK3) or in response to sympathetic activation and lipid/inflammatory mediators, which are present at elevated levels in metabolic disease (GRK2, novel and conventional PKCs, JNK, IKKβ, mPLK). An emerging view is that the positive/negative regulation of IRS by autologous pathways is subverted/co-opted in disease by increased basal and other temporally inappropriate S/T phosphorylation. Compensatory hyperinsulinaemia may contribute strongly to this dysregulation. Here, we examine the links between altered patterns of IRS S/T phosphorylation and the emergence of insulin resistance and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Insulin resistance in adipocytes is associated with impaired phosphorylation of insulin receptor substrate 1 (IRS-1) in obesity, which is further impaired in T2DM”
From Effect of Exercise Training on Fat Loss—Energetic Perspectives and the Role of Improved Adipose Tissue Function and Body Fat Distribution (2021) · cites this paper as Copps and White, 2012
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Insulin Stimulates PKCζ-mediated Phosphorylation of Insulin Receptor Substrate-1 (IRS-1)
Liu, Y., Paz, K., Herschkovitz, A., Alt, A., Tennenbaum, T., Sampson, S. R., Ohba, M., Kuroki, T., LeRoith, D., & Zick, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007281200 · Cited by 159
RetractedHerschkovitz, A., Liu, Y., Ilan, E., Ronen, D., Boura‐Halfon, S., & Zick, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610949200 · Cited by 98
RetractedG Protein–Coupled Receptor Kinase 2 Plays a Relevant Role in Insulin Resistance and Obesity
García‐Guerra, L., Nieto-Vázquez, I., Vila‐Bedmar, R., Jurado-Pueyo, M., Zalba, G., Dı́ez, J., Murga, C., Fernández‐Veledo, S., Mayor, F., & Lorenzo, M. (2010) · Diabetes · doi:10.2337/db10-0771 · Cited by 92
RetractedPhosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · cited 2×
“In contrast, ‘priming’ phosphorylation of AKT at S473—by mammalian target of rapamycin (mTOR) complex 2 (mTORC2) [21] (Fig.”
BackgroundEndoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844 · cited 1×
“phosphorylation is frequently used as evidence of insulin resistance (or its resolution) in mice, despite the influence of insulin on S307 phosphorylation and the probable contribution of other phospho-S/Ts [44].”
BackgroundNewgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.02.002 · Cited by 3,165 · cited 1×
“Increased plasma BCAA levels in obese, insulin-resistant persons have long been regarded as part of an insulin-resistant metabolic ‘signature’ [110, 111], but supplementation of rodent diets with mixed BCAA or leucine has not clarified that this is diabetogenic [111, 112].”
BackgroundSkeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102 · cited 2×
“Prospective studies first identify insulin resistance in human skeletal muscle, which is thought to contribute, via a dys-metabolic process, to the emergence of phenotypic disease [3, 74].”
BackgroundCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,860 · cited 2×
“but not Akt1, gene deletion in mice causes a diabetes-like phenotype [22].”
BackgroundAbsence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
Um, S. H., Frigerio, F., Watanabe, M., Picard, F., Joaquin, M., Sticker, M., Fumagalli, S., Allegrini, P. R., Kozma, S. C., Auwerx, J., et al. (2004) · Nature · doi:10.1038/nature02866 · Cited by 1,677 · cited 3×
“1b); S6K2 can also phosphorylate IRS1 in vitro, but does not compensate for loss of S6K1 in knockout mice [51, 106].”
BackgroundAdipose tissue as an endocrine organ
Galić, S., Oakhill, J. S., & Steinberg, G. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.018 · Cited by 1,654 · cited 1×
“IKKβ and JNK—Impaired glucose uptake and/or insulin resistance within adipose tissue can contribute to the development of type 2 diabetes [164], likely by altering its secretion of adipokines, such as adiponectin or retinol-binding protein 4 (reviewed in [165]).”
Background
Cited by
Sorted by citations
Items 201–300 of 1,000
Francés, D. E., Motiño, O., Agrá, N., González‐Rodríguez, Á., Fernández-Álvarez, A. J., Cucarella, C., Mayoral, R., Castro‐Sánchez, L., García-Casarrubios, E., Boscá, L., et al. (2014) · Diabetes · doi:10.2337/db14-0979 · Cited by 53
“Insulin acts in target cells by binding to its specific receptor and activating a cascade of intracellular signaling events that are altered in inflammation-associated IR (3).”
BackgroundLaw, N. C., & Hunzicker-Dunn, M. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.698761 · Cited by 53
“Extensive research has implicated inhibitory Ser/Thr phosphorylations on IRS1 in the development of type II diabetes, a disease characterized by impaired responses to insulin in target tissues (44, 58).”
BackgroundRole of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
Nagappan, A., Shin, J., & Jung, M. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092109 · Cited by 56
“Additionally, AMP-activated protein kinase (AMPK) and glycogen synthase kinase 3 (GSK3) are insulin-independent kinases that also phosphorylate IRSs and trigger downstream signal transduction [18].”
BackgroundSedgwick, B., Riches, K., Bageghni, S. A., O’Regan, D. J., Porter, K. E., & Turner, N. A. (2014) · Cardiovascular Pathology · doi:10.1016/j.carpath.2014.03.004 · Cited by 52
Al‐Lahham, R., DeFord, J. H., & Papaconstantinou, J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.013 · Cited by 52
Modulation of the action of insulin by angiotensin-(1–7)
Dominici, F. P., Burghi, V., Muñoz, M. C., & Giani, J. F. (2014) · Clinical Science · doi:10.1042/cs20130333 · Cited by 55
Trojan, E., Ślusarczyk, J., Chamera, K., Kotarska, K., Głombik, K., Kubera, M., & Basta‐Kaim, A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00779 · Cited by 54
Gong, X., Hu, H. Z., Qiao, Y., Xu, P., Yang, M., Dang, R., Han, W., Guo, Y., Chen, D., & Jiang, P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00318 · Cited by 52
Kapogiannis, D., Dobrowolny, H., Tran, J., Mustapić, M., Frodl, T., Meyer-Lotz, G., Schiltz, K., Schanze, D., Rietschel, M., Bernstein, H., et al. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2019.08.012 · Cited by 52
Insulin Resistance in Osteoarthritis: Similar Mechanisms to Type 2 Diabetes Mellitus
Tchetina, E. V., Markova, G. A., & Sharapova, E. P. (2020) · Journal of Nutrition and Metabolism · doi:10.1155/2020/4143802 · Cited by 58
“&is hyperphosphorylation results in reduced insulin sensitivity of the insulin receptor, inhibition of insulin signalling, or the uncoupling of IRS-1 and its degradation [28].”
BackgroundRoy, S., Ghosh, A., Majie, A., Karmakar, V., Das, S., Dinda, S. C., Bose, A., & Gorain, B. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155638 · Cited by 58
Current Studies on Molecular Mechanisms of Insulin Resistance
Pei, J., Wang, B., & Wang, D. (2022) · Journal of Diabetes Research · doi:10.1155/2022/1863429 · Cited by 58
“Additionally, it was discovered in cell culture models that PI3K modulates IRS1 phosphorylation at serine sites and inhibits IRS1 signaling [112].”
BackgroundThe Evolving Importance of Insulin Signaling in Podocyte Health and Disease
Lay, A. C., & Coward, R. J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00693 · Cited by 51
“Prolonged activation of mTORC1 has also been linked to insulin-resistance (44), with rapamycin treatment reversing insulin-resistance in these settings (39).”
BackgroundWang, J., Zhu, Q., Cheng, X., Sha, C.-X., & Cui, Y. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1764235 · Cited by 50
Filippi, B., Abraham, M. A., Silva, P. N., Rasti, M., LaPierre, M. P., Bauer, P. V., Rocheleau, J. V., & Lam, T. K. T. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.035 · Cited by 49
Lanzillotta, C., Tramutola, A., Di Giacomo, G., Marini, F., Butterfield, D. A., Di Domenico, F., Perluigi, M., & Barone, E. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.042 · Cited by 47
Promotion of insulin-induced glucose uptake in C2C12 myotubes by osteocalcin
Tsuka, S., Aonuma, F., Higashi, S., Ohsumi, T., Nagano, K., Mizokami, A., Kawakubo‐Yasukochi, T., Masaki, C., Hosokawa, R., Hirata, M., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.123 · Cited by 48
Corzo, C. A., & Griffin, P. R. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.6.395 · Cited by 48
“Whereas tyrosine phosphorylation of the docking proteins is indispensable for efficient insulin action, serine/threonine phosphorylation of IRS1 blocks proper downstream signaling and contributes to the desensitization to insulin in T2DM [20].”
BackgroundInfluentialThe rise and fall of insulin signaling in Alzheimer’s disease
Chami, B., Steel, A. J., de la Monte, S. M., & Sutherland, G. T. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9806-1 · Cited by 48
Wang, J., Tan, J., Qi, Q., Yang, L., Wang, Y., Zhang, C., Hu, L., Chen, H., & Fang, X. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.25052 · Cited by 48
“IRS1, which functions as a crucial signaling effector in the PI3K/Akt and MAPK/Erk pathways [50], was identified as a target gene of miR-487b-3p by bioinformatics analysis, RT-qPCR, western blotting and dual-luciferase reporter gene assay in our study.”
Rebollo‐Hernanz, M., Zhang, Q., Aguilera, Y., Martin-Cabrejas, M. A., & de Mejı́a, E. G. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801413 · Cited by 49
Cong, X. X., Gao, X. K., Rao, X. S., Wen, J., Liu, X. C., Shi, Y. P., He, M. Y., Shen, W., Shen, Y. L., Ouyang, H., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0508-1 · Cited by 48
Fadishei, M., Rahbardar, M. G., Imenshahidi, M., Mohajeri, S. A., Razavi, B. M., & Hosseinzadeh, H. (2020) · Phytotherapy Research · doi:10.1002/ptr.6944 · Cited by 48
“The IRS, Akt, GS3k proteins and their phosphorylated forms play important roles in glucose storage and regulating the blood glucose level by suppressing gluconeogenesis and glucose uptake (Copps & White, 2012).”
BackgroundZou, T., Li, S., Wang, B., Wang, Z., Liu, Y., & You, J. (2021) · Nutrition · doi:10.1016/j.nut.2021.111263 · Cited by 48
Polycystic ovary syndrome and its management: In view of oxidative stress
Bhattacharya, K., Dey, R., Sen, D., Paul, N., Basak, A. K., Purkait, M. P., Shukla, N., Chaudhuri, G. R., Bhattacharya, A., Maiti, R., et al. (2024) · BioMolecular Concepts · doi:10.1515/bmc-2022-0038 · Cited by 52
“OS can lead to IRS serine/threonine phosphorylation, causing IRS to degrade and become an inhibitor of the INSR kinase [112].”
BackgroundGordon, B. S., Steiner, J. L., Williamson, D. L., Lang, C. H., & Kimball, S. R. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00059.2016 · Cited by 49
“phorylate and inhibit insulin receptor substrate-1 (15).”
IRS posttranslational modifications in regulating insulin signaling
Peng, J., & He, L. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0151 · Cited by 49
“Of note, the activation of downstream Ser/Thr kinases ERK1/2 and P70S6K by insulin can also modulate IRS serine and threonine phosphorylation (Copps & White 2012), thus causing the signal to be self-limited.”
Can 14-3-3 proteins serve as therapeutic targets for the treatment of metabolic diseases?
Diallo, K., Oppong, A. K., & Lim, G. E. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.021 · Cited by 41
Dunlop, K., Cedrone, M., Staples, J. F., & Regnault, T. R. H. (2015) · Nutrients · doi:10.3390/nu7021202 · Cited by 45
“A relative increase in the serine phosphorylation of IRS-1, the predominant isoform in skeletal muscle [28], at Ser307 reduces its ability to activate or complex with phosphatidylinositol 3-kinase (PI3-kinase).”
BackgroundInfluentialOng, Q.-R., Chan, E. S., Lim, M.-L., Cole, G. M., & Wong, B.-S. (2014) · Scientific Reports · doi:10.1038/srep03754 · Cited by 44
Yang, J., Hamid, S., Cai, J., Liu, Q., Xu, S., & Zhang, Z. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.07.012 · Cited by 44
Song, L., Liu, J., Shi, T., Zhang, Y., Zhong, X., Cao, X., & Yang, J. (2020) · The FASEB Journal · doi:10.1096/fj.202001639r · Cited by 44
Aging and Insulin Resistance: Just Say iNOS
Evans, J. L., & Goldfine, I. D. (2013) · Diabetes · doi:10.2337/db12-1239 · Cited by 46
“Serine/threonine phosphorylated forms of IRS molecules are less able to associate with the insulin receptor and downstream effector molecules, such as phosphatidylinositol 3-kinase, resulting in the attenuation of insulin action on glucose metabolism and other metabolic functions (7,15).”
BackgroundBishop, C. A., Machate, T., Henning, T., Henkel, J., Püschel, G. P., Weber, D., Grune, T., Klaus, S., & Weitkunat, K. (2022) · Nutrition and Diabetes · doi:10.1038/s41387-022-00200-8 · Cited by 44
“Inhibitory phosphorylation of IRS1 by PKCs, JNK, or mTOR have all been suggested as mediators in IR [43]; however, we observed no effects with that regard in skeletal muscle.”
BackgroundKrisnamurti, D. G. B., Louisa, M., Poerwaningsih, E. H., Tarigan, T. J. E., Soetikno, V., Wibowo, H., & Nugroho, C. M. H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1089298 · Cited by 44
“To date, the increased phosphorylation of IRS1 at serine 307 was considered the best available mechanism to understand the desensitization of insulin signaling (44).”
BackgroundGröger, M., Matsuo, K., Arash, E. H., Pereira, A., Guillou, D. L., Pino, C., Telles-Silva, K. A., Maher, J. J., Hsiao, E. C., & Willenbring, H. (2023) · Nature Communications · doi:10.1038/s41467-023-39311-w · Cited by 47
Xia, F., Cao, S., Wang, M., & Sun, Y. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103007 · Cited by 44
Hakuno, F., Fukushima, T., Yoneyama, Y., Kamei, H., Ozoe, A., Yoshihara, H., Yamanaka, D., Shibano, T., Sone, M., Yu, B., et al. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00073 · Cited by 44
“S6K phosphorylates serine/threonine residues of IRS, which in turn leads to the degradation of IRS protein and attenuation of IGF/insulin signaling (20, 59).”
BackgroundLim, H.-W., & Bernstein, D. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.08.008 · Cited by 47
Jahandideh, F., & Wu, J. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.06.001 · Cited by 48
Luo, Z., Xu, W., Yuan, T., Chen, S., Jin, T., Chong, Y., Ji, J., Lin, L., Xu, J., Zhang, Y., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154595 · Cited by 43
Endoplasmic Reticulum Stress and Its Impact on Adipogenesis: Molecular Mechanisms Implicated
Kim, G., Lee, J., Ha, J., Kang, I., & Choe, W. (2023) · Nutrients · doi:10.3390/nu15245082 · Cited by 47
“IRS-1 and insulin receptor substrate-2 (IRS-2) play a vital role as substrates for the insulin receptor tyrosine kinase in the insulin signaling pathway [223,224].”
BackgroundWilhelm, A., Lopez-Garcia, L. A., Busschots, K., Fröhner, W., Maurer, F., Boettcher, S., Zhang, H., Schulze, J. O., Biondi, R. M., & Engel, M. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3010477 · Cited by 43
Law, N. C., Donaubauer, E. M., Zeleznik, A. J., & Hunzicker-Dunn, M. E. (2017) · Endocrinology · doi:10.1210/en.2017-00163 · Cited by 43
Keegan, A. D., Zamorano, J., Keselman, A. M., & Heller, N. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01037 · Cited by 44
“In addition to stimulating positive pathways, TORC1 induces a negative feedback loop which in the insulin signaling pathway leads to serine phosphorylation of IRS1 and reduced insulin receptor signaling (33, 128).”
BackgroundCurrent research status of blood biomarkers in Alzheimer’s disease: Diagnosis and prognosis
Feng, L., Li, J., & Zhang, R. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101492 · Cited by 45
Park, J. E., Kang, E., & Han, J.-S. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174884 · Cited by 42
Fang, J., Wu, X., He, J., Zhang, H., Chen, X., Zhang, H., Novakovic, B., Qi, H., & Yu, X. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00615-8 · Cited by 45
Schisandra polysaccharide increased glucose consumption by up-regulating the expression of GLUT-4
Dun, J., Zhao, T., Feng, W., Mao, G., Zou, Y., Wang, W., Li, Q., Chen, Y., Wang, X.-T., Yang, L., et al. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.03.028 · Cited by 44
Nguyễn, T. D., Schwarzer, M., Schrepper, A., Amorim, P., Blum, D. J., Hain, C., Färber, G., Haendeler, J., Altschmied, J., & Doenst, T. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008865 · Cited by 42
“considered a key mechanism of insulin resistance in diabetes mellitus.(20) In addition, recent findings have also linked IRS1 to the regulation of mitochondrial function in the heart.”
BackgroundInfluentialBrain Insulin Resistance: Focus on Insulin Receptor-Mitochondria Interactions
Анатольевич, П. И., & Pinelis, V. G. (2021) · Life · doi:10.3390/life11030262 · Cited by 43
“downstream effectors PI3K, Akt, and mTOR, which in turn phosphorylate IRS at serine/threonine residues (pS), thereby inhibiting insulin signaling [15-17].”
BackgroundMazzei, G., Ikegami, R., Abolhassani, N., Haruyama, N., Sakumi, K., Saito, T., Saido, T. C., & Nakabeppu, Y. (2021) · Aging Cell · doi:10.1111/acel.13429 · Cited by 40
“The hyperphosphorylation of AKT is known to increase phosphorylation of serine residues of IRS1 through activation of mTOR pathway (Copps & White, 2012).”
BackgroundCopps, K. D., Hançer, N. J., Qiu, W., & White, M. F. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.714915 · Cited by 41
Self-citationQi, X., Guo, Y., Song, Y., Yu, C., Zhao, L., Li, F., Kong, D., Zhao, J., & Gao, L. (2018) · Diabetologia · doi:10.1007/s00125-018-4562-x · Cited by 41
Zhang, Y., Xie, J., Xu, X., Hu, J., Xu, T., Jin, S., Yang, S., & Wang, J. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-018-00336-7 · Cited by 44
Perspectives on the role of PTEN in diabetic nephropathy: an update
Khokhar, M., Roy, D., Modi, A., Agarwal, R. G., Yadav, D., Purohit, P., & Sharma, P. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1746735 · Cited by 43
Woo, Y. S., Lim, H. K., Wang, S., & Bahk, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186969 · Cited by 43
“Insulin signaling pathways are triggered by the binding of ligands such as insulin-like growth factor (IGF) 1 and 2 and insulin to the transmembrane IR, and it induces several downstream signaling events involving different insulin-induced kinases such as PKC, AKT, mTOR, S6K1, SIK2, extracellular signal-regulated kina…”
BackgroundMelnik, B. C. (2021) · Biomolecules · doi:10.3390/biom11030404 · Cited by 47
Alshehade, S. A., Alshawsh, M. A., Murugaiyah, V., Asif, M., Alshehade, O., Almoustafa, H. A., & Zarzour, R. H. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120732 · Cited by 42
Molecular mechanisms linking stress and insulin resistance
Yaribeygi, H., Maleki, M., Butler, A. E., Jamialahmadi, T., & Sahebkar, A. (2021) · EXCLI journal · doi:10.17179/excli2021-4382 · Cited by 59
“…target of rapamycin), ROCK1 (rho-associated protein kinase-1), AMPK (AMP-activated protein kinase) and GSK3 (glycogen synthase kinase) which are also able to phosphorylate IRSs and facilitate insulin signal transduction (Kiselyov et al., 2009; Copps and White, 2012; Petersen and Shulman, 2018).”
BackgroundGonçalves, A. C., Nunes, A. R., Flores‐Félix, J. D., Alves, G., & Silva, L. R. (2022) · Molecules · doi:10.3390/molecules27103294 · Cited by 40
Zhang, S., Zhang, S., Zhang, Y., Wang, H., Chen, Y., & Lü, H. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117931 · Cited by 46
Li, S.-W., Yu, H., Sheen, J., Tiao, M., Tain, Y., Lin, I.-C., Lin, Y., Chang, K., Tsai, C., & Huang, L. (2017) · Oncotarget · doi:10.18632/oncotarget.22960 · Cited by 44
“Insulin sensitivity is known to be regulated via serine/threonine phosphorylation of IRS-1, in which phospho-IRS-1-Ser636 was associated with desensitization of insulin signaling [27].”
BackgroundMethodZhan, Y., Wang, J., He, X., Huang, M., Yang, X., He, L., Qiu, Y., & Lou, Y. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.02.023 · Cited by 42
Chen, G. (2021) · Cells · doi:10.3390/cells10082160 · Cited by 40
“further modifications of downstream proteins [27], such as the regulatory subunits of phosphatidylinositol 3-kinase (PI3K), growth factor receptor-bound protein 2, and protein tyrosine phosphatase-2 [28].”
BackgroundmTOR Dysregulation, Insulin Resistance, and Hypertension
Stanciu, S. M., Jinga, M., Miricescu, D., Ștefani, C., Nica, R. I., Stănescu-Spînu, I.-I., Văcăroiu, I. A., Greabu, M., & Nica, S. (2024) · Biomedicines · doi:10.3390/biomedicines12081802 · Cited by 44
“Therefore, IRS dysregulation is involved in metabolic disease initiation and progression [87].”
BackgroundProtein Scaffolds Control Localized Protein Kinase Cζ Activity*
Tobias, I. S., & Newton, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.729483 · Cited by 37
“IRS-1 is a large docking hub for downstream insulin signaling events to occur (25) and possesses Ser/Thr phosphorylation sites previously shown to be regulated by aPKC (65–68).”
BackgroundZhu, M. J., Kang, Y., Xue, Y., Liang, X., García, M. P. G., Rodgers, D. B., Kagel, D. R., & Du, . (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.10.012 · Cited by 38
Loss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction
Cruz, V. H., Arner, E. N., Wynne, K. W., Scherer, P. E., & Brekken, R. A. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.007 · Cited by 40
“Persistent inhibitory phosphorylation of IRS1 leads to its degradation and ultimately insulin resistance [27].”
Differential regulation of mTORC1 and mTORC2 is critical for 8-Br-cAMP-induced decidualization
Baek, M., Song, H.-I., Han, J., & Yoon, M. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0165-3 · Cited by 39
Characterization and Hypoglycemic Activity of a Rhamnan-Type Sulfated Polysaccharide Derivative
Cui, J., Ye, H., Zhu, Y., Li, Y.-P., Wang, J., & Wang, P. (2019) · Marine Drugs · doi:10.3390/md17010021 · Cited by 39
Cimini, F. A., Arena, A., Barchetta, I., Tramutola, A., Ceccarelli, V., Lanzillotta, C., Fontana, M., Bertoccini, L., Leonetti, F., Capoccia, D., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.02.021 · Cited by 39
Chatterjee, S., Ambegaokar, S. S., Jackson, G. R., & Mudher, A. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00801 · Cited by 40
“It has been observed in human hippocampal tissue that insulin resistance is accompanied by an increased phosphorylation at the Serine636 residues of IRS-1 (Copps and White, 2012; Diehl et al., 2017).”
BackgroundZhu, W., Niu, X., Wang, M., Zhao, L., Jiang, H., Chun-tao, L., Caton, S. J., & Bai, Y. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s218336 · Cited by 39
“It has been shown that IRS-mediated INS receptor signaling dysregulation is a common underlying mechanism that can produce and exacerbate INS resistance in many genetic and physiological factors.(62,63) INS signaling in adipocytes is critical for the development of obesity.”
BackgroundZhang, Y., Li, J., Wang, Z., Xu, M.-Z., Zeng, Z., Huang, J., & Guan, Y. (2020) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.124630 · Cited by 40
Campodonico-Burnett, W., Hetrick, B., Wesolowski, S. R., Schenk, S., Takahashi, D. L., Dean, T. A., Sullivan, E. L., Kievit, P., GANNON, M. A., Aagaard, K. M., et al. (2020) · Diabetes · doi:10.2337/db19-1218 · Cited by 39
Nicotine’ actions on energy balance: Friend or foe?
Seoane‐Collazo, P., Diéguez, C., Nogueiras, R., Rahmouni, K., Fernández‐Real, J. M., & López, M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107693 · Cited by 42
“Subsequently, this blunts insulin-stimulated IRS1 tyrosine phosphorylation, phosphatidylinositol 3-kinase activity, and glucose uptake leading to IR (Copps & White, 2012; Petersen & Shulman, 2018).”
Xie, S.-Z., Zhang, W.-J., Liu, P., Bai, J.-B., Xie, S.-L., Wang, T., Xu, G.-B., & Wu, D. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105080 · Cited by 38
Warren, K. J., Fang, X., Gowda, N. M., Thompson, J. J., & Heller, N. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.756791 · Cited by 38
Consequences of gestational diabetes to the brain and behavior of the offspring
Sousa, R. A. L. D., TORRES, Y. S., Figueiredo, C. P., Passos, G. F., & Clarke, J. R. (2017) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201720170264 · Cited by 41
Drissi, F. D., LAHFA, F. B., Gonzalez, T., Peiretti, F., Tanti, J., Haddad, M., Fabre, N., & Govers, R. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113772 · Cited by 40
Integrating Metabolism and Longevity Through Insulin and IGF1 Signaling
Sadagurski, M., & White, M. F. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.11.008 · Cited by 39
Self-citationCreatine supplementation and glycemic control: A systematic review
Pinto, C. L., Botelho, P. B., Pimentel, G. D., Campos-Ferraz, P. L., & Mota, J. F. (2016) · Amino Acids · doi:10.1007/s00726-016-2277-1 · Cited by 37
Abu-Samra, N., Jelinek, H. F., AlSafar, H. S., Asghar, F., Seoud, M. A.-F., Hussein, S. M., Mubarak, H. M., Anwar, S., Memon, M., Afify, N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073514 · Cited by 41
Kang, C., Park, M., & Lee, H. (2022) · Life · doi:10.3390/life12101630 · Cited by 37
“The IRS-1/PI3K/Akt pathway is one of the most important signaling pathways that regulate insulin resistance and glucose homeostasis, and its activation is essential for normal insulin-mediated glucose metabolism in the skeletal muscle [11,12].”
BackgroundInsulin resistance, metabolic syndrome and polycystic ovaries: an intriguing conundrum
Prosperi, S., & Chiarelli, F. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1669716 · Cited by 58
Chou, S., Chan, L., Chung, C., Chiu, J.-Y., Hsieh, Y., & Hong, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.564641 · Cited by 35
“The levels of p-IRS-1/total IRS-1, therefore, can be cellular markers of the function of insulin signaling pathway (Copps and White, 2012).”
BackgroundNardi, F., Lipina, C., Magill, D., Hage Hassan, R., Hajduch, E., Gray, A., & Hundal, H. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092255 · Cited by 36
“palmitate) result in tissue accumulation of lipotoxic fatty acid derivatives such as diacylglycerol (DAG) and ceramide that promote activation of (i) DAG-sensitive PKCs, (ii) atypical PKCs and (iii) PP2A that, in turn, impair IRS- and Akt-directed insulin signalling by mechanisms involving IRS serine phosphorylation o…”
BackgroundLow-Carbohydrate High-Fat Diet: A SWOC Analysis
Nuwaylati, D. A., Eldakhakhny, B. M., Bima, A. I. H., Sakr, H. F., & Elsamanoudy, A. Z. (2022) · Metabolites · doi:10.3390/metabo12111126 · Cited by 39
Kimball, R., Wayment, M., Merrill, D., Wahlquist, T., Reynolds, P. R., & Arroyo, J. A. (2015) · Physiological Reports · doi:10.14814/phy2.12651 · Cited by 34
Yaluri, N., Modi, S. R., & Kokkola, T. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.026 · Cited by 36
“Moreover, it can be regulated by several kinases involved in other pathways such as JNK1 (c-Jun N-terminal kinase 1), mTOR (mammalian target of rapamycin) S6K1 (ribosomal protein S6 kinase beta-1) kinase pathway, GRK2 (G protein-coupled receptor kinase 2) and some PKC (protein kinase C) isoforms [20].”
BackgroundCorrelates of insulin clearance in apparently healthy non-obese Japanese men
Kaga, H., Tamura, Y., Takeno, K., Kakehi, S., Funayama, T., Furukawa, Y., Nishitani‐Yokoyama, M., Shimada, K., Daida, H., Aoki, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01469-x · Cited by 36
The Destiny of Glucose from a MicroRNA Perspective
Mirra, P., Nigro, C., Prevenzano, I., Leone, A., Raciti, G. A., Formisano, P., Bèguinot, F., & Miele, C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00046 · Cited by 40
“Abbreviations: PTP1B, protein tyrosine phosphatase 1B; SOCS1/3, suppressor of cytokine signaling 1/3; S6K1, Ribosomal protein S6 kinase beta 1 IKKβ, inhibitor of nuclear factor kappa-B kinase subunit beta; SHIP2, SH2-containing 5′-inositol phosphatase; PTEN, phosphatase and tensin homolog; PHLPP1/2, PH domain and leuc…”
BackgroundInfluentialA Boolean network of the crosstalk between IGF and Wnt signaling in aging satellite cells
Siegle, L., Schwab, J. D., Werle, S. D., Lausser, L. M., Tümpel, S., Pfister, A. S., Kühl, M., & Kestler, H. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195126 · Cited by 36
Qiu, N., He, Y., Zhang, S., Zhan, Y., Han, G., Jiang, M., He, W., Zhou, J., Liang, H., Ao, X., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.08.008 · Cited by 36
Durrani, I. A., Bhatti, A., & John, P. C. L. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02040-5 · Cited by 46
“Hyperinsulinemia Increased phosphorylation of IRS proteins prevents tyrosine phosphorylation leading to insulin resistance [139], which leads to compensatory hyperinsulinemia.”
BackgroundUpdated Understanding of the Crosstalk Between Glucose/Insulin and Cholesterol Metabolism
Xiao, X., Luo, Y., & Peng, D. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.879355 · Cited by 66
“The hypoglycemic effect exerted by insulin is initiated by the combination of insulin to INSR, thereby triggering the insulin signaling, including the phosphorylation of IRSs and then the activation of various kinases (such as Akt, hepatic p70 S6 kinase (S6K1), and mTOR) (88, 89).”
BackgroundPhase separation of insulin receptor substrate 1 drives the formation of insulin/IGF-1 signalosomes
Gao, X. K., Rao, X. S., Cong, X. X., Sheng, Z. K., Sun, Y. T., Xu, S. B., Wang, J. F., Liang, Y., Lu, L., Ouyang, H., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00426-x · Cited by 36
An estrogen receptor α-derived peptide improves glucose homeostasis during obesity
Yang, W., Jiang, W., Liao, W., Yan, H., Ai, W., Pan, Q., Brashear, W. A., Xu, Y., He, L., & Guo, S. (2024) · Nature Communications · doi:10.1038/s41467-024-47687-6 · Cited by 38
“IRS1 andIRS2 contain ahighlysimilaramino-terminal pleskstrin homology (PH) and phosphostyrosin-binding domain (PTB), whereas the tail region of IRS1 and IRS2 are poorly conserved 14 .”
The Role of PTP1B O-GlcNAcylation in Hepatic Insulin Resistance
Zhao, Y., Tang, Z., Shen, A., Tao, T., Wan, C., Zhu, X., Huang, J., Zhang, W., Xia, N., Wang, S., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922856 · Cited by 35
“Activated IR phosphorylates the downstream docking protein insulin receptor substrate 1 (IRS-1), which, subsequently, through the activation of the phosphatidylinositol 3-kinase (PI3K) and Akt/protein kinase B (PKB) pathway, leads to the translocation of glucose transporter type 4 (GLUT4) vesicles to the cell surface…”
Background
Metadata
- Authors
- Copps, K. D., & White, M. F.
- Affiliations
- Boston Children's Hospital (US)
- Corresponding author
- White, M. F.
- ORCID
- White, M. F.
- Venue
- Diabetologia
- Published
- 2012-08-08
- Volume
- 55
- Issue
- 10
- Pages
- 2565-2582
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC4011499
- OpenAlex
- W1982479748
- Cited by
- 1,017
- References
- 185
- Citations by year
- 2026: 72 · 2025: 56 · 2024: 76 · 2023: 83 · 2022: 103 · 2021: 113 · 2020: 83 · 2019: 76 · 2018: 75 · 2017: 70 · 2016: 59 · 2015: 63 · 2014: 51 · 2013: 31 · 2012: 5
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health (5r01dk098655-08)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01- DK098655, R01DK038712)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin receptor substrate, IRS-1, insulin receptor substrate 2, serine/threonine phosphorylation, insulin sensitivity, insulin resistance, diabetes mellitus, insulin signaling, AMPK, glycogen synthase kinase-3, protein kinase C, Akt, mTOR, hyperinsulinemia, metabolic disorders
- MeSH terms
- Animals, Diabetes Mellitus, Humans, Insulin Resistance, Mice, Transgenic, Phosphorylation, Serine, Threonine, Signal Transduction, Mice, Knockout, Models, Animal, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review